SE9603668D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SE9603668D0 SE9603668D0 SE9603668A SE9603668A SE9603668D0 SE 9603668 D0 SE9603668 D0 SE 9603668D0 SE 9603668 A SE9603668 A SE 9603668A SE 9603668 A SE9603668 A SE 9603668A SE 9603668 D0 SE9603668 D0 SE 9603668D0
- Authority
- SE
- Sweden
- Prior art keywords
- undesirable
- compositions
- pharmaceutical compositions
- hmg
- sustained release
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to pharmaceutical compositions for sustained release of HMG-CoA reductase inhibitors, in particular fluvastatin. The said compositions are useful for the treatment of hypercholesterolemia, and have the further advantages of (i) decreasing the incidence of undesirable gastro-intestinal side-effects, and (ii) avoiding undesirable increases of serum transaminase levels. Furthermore, undesirable up-regulation of HMG-CoA reductase levels is significantly reduced by administration of the said sustained release compositions.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603668A SE9603668D0 (en) | 1996-10-08 | 1996-10-08 | Pharmaceutical compositions |
PCT/SE1997/001605 WO1998015290A1 (en) | 1996-10-08 | 1997-09-24 | PHARMACEUTICAL COMPOSITIONS COMPRISING HMG-CoA REDUCTASE INHIBITORS, IN PARTICULAR FLUVASTATIN |
AU45781/97A AU4578197A (en) | 1996-10-08 | 1997-09-24 | Pharmaceutical compositions comprising hmg-coa reductase inhibitors, in particular fluvastatin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603668A SE9603668D0 (en) | 1996-10-08 | 1996-10-08 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9603668D0 true SE9603668D0 (en) | 1996-10-08 |
Family
ID=20404166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9603668A SE9603668D0 (en) | 1996-10-08 | 1996-10-08 | Pharmaceutical compositions |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4578197A (en) |
SE (1) | SE9603668D0 (en) |
WO (1) | WO1998015290A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
WO2007016757A1 (en) * | 2005-08-05 | 2007-02-15 | Orbus Pharma Inc. | Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor |
US20100196469A1 (en) * | 2007-06-25 | 2010-08-05 | Pharmathen S.A. | Pharmaceutical Formulation containing an HMG-COA Reductase Inhibitor and method for the preparation thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2045428A1 (en) * | 1990-06-26 | 1991-12-27 | Alfred W. Alberts | Method for enhancing the lowering of plasma cholesterol levels |
HU217629B (en) * | 1991-12-12 | 2000-03-28 | Novartis Ag. | Process for producing stabilized pharmaceutical compositions comprising fluvastatin |
-
1996
- 1996-10-08 SE SE9603668A patent/SE9603668D0/en unknown
-
1997
- 1997-09-24 WO PCT/SE1997/001605 patent/WO1998015290A1/en active Application Filing
- 1997-09-24 AU AU45781/97A patent/AU4578197A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4578197A (en) | 1998-05-05 |
WO1998015290A1 (en) | 1998-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0004318A2 (en) | Pharmaceutical composition comprising atorvastatin and an antihypertensive agent | |
RU2008111710A (en) | COMPOSITION FOR EMERGENCY DELIVERY OF MEDICINES | |
DE69720778D1 (en) | MEDICINES FOR DELAYED RELEASE OF HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN | |
GEP20063956B (en) | Cell adhesion inhibitors | |
WO1999006035A3 (en) | COMBINATIONS OF HMG-CoA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT | |
WO1998040375A3 (en) | COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS | |
WO2002024194A3 (en) | Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent | |
CA2297764A1 (en) | Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia | |
ATE283050T1 (en) | DELAYED RELEASE COMPOSITIONS FOR THE TREATMENT OF HYPERLIPIDEMIA | |
BR9714364A (en) | Apo b / mtp secretion inhibiting amides | |
MY138289A (en) | Pharmaceutical compositions | |
NO20016007L (en) | Recombinant anti-CD40 antibody and uses thereof | |
TR200000561T2 (en) | Therapeutic compounds containing amlodipine and atorvastatin. | |
AP1745A (en) | Pharmaceutical compositions of amlodipine and atorvastatin. | |
PL343018A1 (en) | Glucocorticoid-selective anti-inflammatory agents | |
DK1053240T3 (en) | Glucocorticoid-selective anti-inflammatory agents | |
ATE260658T1 (en) | PHARMACEUTICAL PREPARATIONS FOR REDUCING RESPIRATORY DEPRESSION | |
DE69725860D1 (en) | PLAN FOR ADMINISTRATION OF H +, K + -ATPase INHIBITORS | |
ZA967880B (en) | Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha | |
DE69720996D1 (en) | NEW PHARMACEUTICAL COMPOSITIONS OF STEROID NITRATE ESTER FOR USE AS AN INFLAMMATORY INHIBITOR | |
SE9603668D0 (en) | Pharmaceutical compositions | |
ATE342261T1 (en) | PYRAND DERIVATIVES AS INHIBITORS OF ACE AND NEP | |
WO2001091796A8 (en) | Methods, compounds and compositions for treating gout | |
AU1572301A (en) | Cyclopentyl sulfonamide derivatives | |
EA199901043A1 (en) | PHARMACEUTICAL TRANSFERASE INHIBITORS IN A COMBINATION WITH HMG-CoA REDUCTASE INHIBITORS FOR CANCER TREATMENT |